Works matching IS 2160763X AND DT 2016 AND VI 5 AND IP 4
Results: 10
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 259, doi. 10.1002/cpdd.237
- By:
- Publication type:
- Article
Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 250, doi. 10.1002/cpdd.253
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 241, doi. 10.1002/cpdd.227
- Publication type:
- Article
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 296, doi. 10.1002/cpdd.240
- By:
- Publication type:
- Article
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 314, doi. 10.1002/cpdd.241
- By:
- Publication type:
- Article
A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 278, doi. 10.1002/cpdd.242
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 306, doi. 10.1002/cpdd.244
- By:
- Publication type:
- Article
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 285, doi. 10.1002/cpdd.245
- By:
- Publication type:
- Article
Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 269, doi. 10.1002/cpdd.246
- By:
- Publication type:
- Article
Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 245, doi. 10.1002/cpdd.265
- By:
- Publication type:
- Article